Free Trial

Profound Medical (PROF) Stock Price, News & Analysis

Profound Medical logo
$5.81 -0.27 (-4.44%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$5.88 +0.07 (+1.20%)
As of 07/11/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Profound Medical Stock (NASDAQ:PROF)

Key Stats

Today's Range
$5.81
$6.09
50-Day Range
$4.04
$6.79
52-Week Range
$3.90
$11.42
Volume
25,739 shs
Average Volume
65,536 shs
Market Capitalization
$174.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.50
Consensus Rating
Buy

Company Overview

Profound Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
55th Percentile Overall Score

PROF MarketRank™: 

Profound Medical scored higher than 55% of companies evaluated by MarketBeat, and ranked 513th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Profound Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Profound Medical has only been the subject of 2 research reports in the past 90 days.

  • Read more about Profound Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Profound Medical are expected to grow in the coming year, from ($1.12) to ($0.78) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Profound Medical is -4.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Profound Medical is -4.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Profound Medical has a P/B Ratio of 2.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Profound Medical's valuation and earnings.
  • Percentage of Shares Shorted

    2.07% of the float of Profound Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Profound Medical has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in Profound Medical has recently increased by 3.41%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Profound Medical does not currently pay a dividend.

  • Dividend Growth

    Profound Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.07% of the float of Profound Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Profound Medical has a short interest ratio ("days to cover") of 9.
  • Change versus previous month

    Short interest in Profound Medical has recently increased by 3.41%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Profound Medical has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.00 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Profound Medical this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Profound Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $100,201.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 1.52% of the stock of Profound Medical is held by insiders.

  • Percentage Held by Institutions

    47.86% of the stock of Profound Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Profound Medical's insider trading history.
Receive PROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PROF Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Headlines

PROF Stock Analysis - Frequently Asked Questions

Profound Medical's stock was trading at $7.51 at the beginning of 2025. Since then, PROF stock has decreased by 22.6% and is now trading at $5.81.

Profound Medical (NASDAQ:PROF) posted its quarterly earnings results on Thursday, May, 8th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.29) by $0.07. The company had revenue of $2.62 million for the quarter, compared to analysts' expectations of $4.78 million. Profound Medical had a negative trailing twelve-month return on equity of 70.41% and a negative net margin of 269.35%.
Read the conference call transcript
.

Shares of PROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include Alibaba Group (BABA), Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Tesla (TSLA) and Docusign (DOCU).

Company Calendar

Last Earnings
5/08/2025
Today
7/12/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PROF
CIK
1628808
Employees
150
Year Founded
N/A

Price Target and Rating

High Price Target
$12.00
Low Price Target
$11.00
Potential Upside/Downside
+97.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$27.82 million
Net Margins
-269.35%
Pretax Margin
-269.38%
Return on Equity
-70.41%
Return on Assets
-57.22%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
11.31
Quick Ratio
10.03

Sales & Book Value

Annual Sales
$10.68 million
Price / Sales
16.35
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.01 per share
Price / Book
2.89

Miscellaneous

Outstanding Shares
30,050,000
Free Float
29,596,000
Market Cap
$174.59 million
Optionable
Optionable
Beta
0.49
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:PROF) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners